These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 16180961)

  • 41. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
    Chan J; Sweeting M
    J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of antipsychotics in first line].
    Stefos G
    Rev Med Brux; 2004 Sep; 25(4):A302-7. PubMed ID: 15516061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic side effects of atypical antipsychotics in children: a literature review.
    Fedorowicz VJ; Fombonne E
    J Psychopharmacol; 2005 Sep; 19(5):533-50. PubMed ID: 16166191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment-emergent adverse events associated with atypical antipsychotics.
    Cha DS; McIntyre RS
    Expert Opin Pharmacother; 2012 Aug; 13(11):1587-98. PubMed ID: 22304541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of the effect of atypical antipsychotics on weight.
    Nasrallah H
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.
    Chue P; Kovacs CS
    Bipolar Disord; 2003; 5 Suppl 2():62-79. PubMed ID: 14700015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.
    Slim M; Medina-Caliz I; Gonzalez-Jimenez A; Cabello MR; Mayoral-Cleries F; Lucena MI; Andrade RJ
    Drug Saf; 2016 Oct; 39(10):925-43. PubMed ID: 27449495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical antipsychotics and the burden of disease.
    Simpson GM
    Am J Manag Care; 2005 Sep; 11(8 Suppl):S235-41. PubMed ID: 16180961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of bipolar mania with atypical antipsychotics.
    Chengappa KN; Suppes T; Berk M
    Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging treatments for bipolar disorder: safety and adverse effect profiles.
    Marken PA; Pies RW
    Ann Pharmacother; 2006 Feb; 40(2):276-85. PubMed ID: 16403851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.